Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control
about
Impact of insect salivary proteins in blood feeding, host immunity, disease, and in the development of biomarkers for vector exposureDescription of a nanobody-based competitive immunoassay to detect tsetse fly exposureSalivary Biomarkers in the Control of Mosquito-Borne DiseasesHuman IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission AreaHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, AngolaSerological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.Serological responses and biomarker evaluation in mice and pigs exposed to tsetse fly bites.Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communitiesIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectorsIn silico identification of a candidate synthetic peptide (Tsgf118-43) to monitor human exposure to tsetse flies in West Africa.IgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso.Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva.Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in TunisiaSpecific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.Gene expression changes in the salivary glands of Anopheles coluzzii elicited by Plasmodium berghei infectionAn. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species.Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Identification of a Tsal152-75 salivary synthetic peptide to monitor cattle exposure to tsetse flies.gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.Malaria diagnostics in clinical trials.Needs for monitoring mosquito transmission of malaria in a pre-elimination world.Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and LeishmaniaSolute carriers affect Anopheles stephensi survival and Plasmodium berghei infection in the salivary glands.Operational Assessment of Long-Lasting Insecticidal Nets by Using an Anopheles Salivary Biomarker of Human-Vector Contact.Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.Human antibody response to Aedes albopictus salivary proteins: a potential biomarker to evaluate the efficacy of vector control in an area of Chikungunya and Dengue Virus transmission.Spatio-temporal variations of Anopheles coluzzii and An. gambiae and their Plasmodium infectivity rates in Lobito, Angola.First screening of Aedes albopictus immunogenic salivary proteins.Proteomic analysis of salivary glands of female Anopheles barbirostris species A2 (Diptera: Culicidae) by two-dimensional gel electrophoresis and mass spectrometry.Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the PacificEvaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to Bites
P2860
Q26314430-A85185B1-D54C-48F3-BD82-FF75D7E84547Q27304633-1A2E560A-69F4-4EBE-A093-59267346FECAQ28085738-EC27A00D-9C7A-4401-8602-EC81239CDAB6Q28119695-9C961D62-7900-4C70-B88C-6A7936A76FB4Q31101514-3D72705A-BB10-4221-B16A-DC8C0CAA2078Q33604400-70FFF2CB-D45D-4D09-9107-CD2E53F04826Q33650544-69B9F3D5-420F-44F8-B5E4-ACC02AB19188Q33793094-498ED96B-C20F-4D97-813D-698CF8318ED6Q34328747-C0236667-1CBD-4211-9251-FD30954541F6Q34483155-3EDB47C0-7595-4BAC-8C7F-BF62C946EE4CQ34620299-846883E7-300E-401F-8D25-26031FC0F1EDQ35006535-803EBAF9-736B-442A-9BE9-01C91D95AE13Q35156245-6F5FB5E5-EEA0-49F4-BD0E-A0EB754ECED3Q35562509-0882EBDB-CC01-4FF2-AA40-93859CD1E76FQ35564409-EA50699C-9708-49FE-BD3B-81D203C9B0F7Q35774617-0AEC6B19-08FD-4166-8FA2-DFEBA89EF980Q35880068-564E1414-E6C8-4F9A-80A4-B7EA525E7EFDQ35916023-CB3E246D-FAA6-4F28-BB3D-6E2D57396B7EQ36086643-D179524E-58BD-4859-9065-D55FFFF979B4Q36160018-3915BB6C-62F3-4509-91E0-BC950942F674Q36279030-95FBFF61-7E84-4C9F-8A84-1F484FF3D14FQ36521143-E183FFBE-991B-4372-BC6E-194BE426F2EFQ36686937-9602E3A0-2E48-4234-9A05-C82018619224Q36780477-C1C09337-3B4B-4AD2-B104-2B875139FFA5Q36945208-34266AA6-94FA-4651-9FE3-E1E266E545EDQ37153769-1DD775B6-4BD7-4D45-B1EB-1DC9812AF518Q37287631-E527063E-BD60-4491-8B80-6C54B09046B0Q37456170-26DA8F98-8874-4BA5-9360-857E814B27AEQ38680919-901DA467-36F3-4395-9958-8E52CA703E60Q38955078-4EFFD551-8639-4FBD-975E-E4D1E8DA72E8Q39121517-41DF11D7-DB66-4C8A-A22B-1032277CBD9AQ39609570-7CCA81EF-36F9-4627-BB48-BA44AAB6B8DEQ40190852-A7DC40D3-CBAA-4455-AA15-6AAE46A49144Q41691062-9C334F59-4E5B-44CF-85F6-ADBA6DCDBAD5Q42992616-D1E9C5A6-7D4A-4EAD-9C22-5DB58DC31C9BQ44163984-7181B31C-A022-4113-B6DC-AE65C6C64138Q56344147-197C9E9F-F9EA-4087-A638-2BF25714A73FQ56381103-2801E39B-FE3A-46CF-9F33-46BA75038401
P2860
Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human antibody responses to th ...... ITNs in malaria vector control
@ast
Human antibody responses to th ...... ITNs in malaria vector control
@en
Human antibody responses to th ...... ITNs in malaria vector control
@nl
type
label
Human antibody responses to th ...... ITNs in malaria vector control
@ast
Human antibody responses to th ...... ITNs in malaria vector control
@en
Human antibody responses to th ...... ITNs in malaria vector control
@nl
prefLabel
Human antibody responses to th ...... ITNs in malaria vector control
@ast
Human antibody responses to th ...... ITNs in malaria vector control
@en
Human antibody responses to th ...... ITNs in malaria vector control
@nl
P2093
P2860
P1433
P1476
Human antibody responses to th ...... ITNs in malaria vector control
@en
P2093
Filomeno Fortes
Franck Remoue
Jacques Le Mire
Jean-Claude Toto
Maria Adelaide Dos-Santos
Mbacké Sembène
Papa Makhtar Drame
Patrick Besnard
Pierre Carnevale
Sylvie Cornelie
P2860
P304
P356
10.1371/JOURNAL.PONE.0015596
P407
P577
2010-12-14T00:00:00Z